 I. To assess safety and acute toxicity of SBRT followed by prostatectomy. This will be based on Common Terminology Criteria for Adverse Events CTCAE version 4.0 and patient reported quality of life Expanded Prostate Cancer Index Composite EPIC and International Prostate Symptom Score IPSS questionnaires. 